References
- World Health Organization. Antibiotic resistance: global report on surveillance 2014. World Health Organization; 2014.
- Organization for Economic Cooperation and Development. Stemming the superbug tide: just a few dollars more. November 7, 2018.
- Mishra RP, Oviedo-Orta E, Prachi P, et al. Vaccines and antibiotic resistance. Curr Opin Microbiol. 2012;15:596–602.
- de Kraker MEA, Stewardson AJ, Harbarth S. Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Med. 2016;13(11):e1002184.
- Jansen KU. Anderson AS The role of vaccines in fighting antimicrobial resistance (AMR). Hum Vaccin Immunother. 2018;14(9):2142–2149.
- ONeil J. Review on antimicrobial resistance tackling drug-resistant infections globally: final report and recommendations. London UK; 2016 July.
- Lipsitch M, Siber GR. How can vaccines contribute to solving the antimicrobial resistance problem? mBio. 2106;7(3):e00428–16.
- Atkins KE, Flasche S. Vaccination to reduce antimicrobial resistance. Lancet Glob Health. 2018;6(3):e252.
- Maman K, Zöllner Y, Greco D, et al. The value of childhood combination vaccines: from beliefs to evidence. Hum Vaccin Immunother. 2015;11(9):2132–2141.
- Gheibi Hayat SM, Darroudi M. Nanovaccine: A novel approach in immunization. J Cell Physiol. 2019;(234)2–7.
- Tomczyk S, Lynfield R, Schaffner W, et al. Prevention of antibiotic-nonsusceptible invasive pneumococcal disease with the 13-valent pneumococcal conjugate vaccine. Clin Infect Dis. 2016;62(9):1119–1125.
- Jansen KU, Knirsch C, Anderson AS. The role of vaccines in preventing bacterial antimicrobial resistance. Nat Med. 2018 Jan 9;24(1):10–19.
- Centers for disease control and prevention, national center for emerging and zoonotic infectious diseases, division of healthcare quality promotion 2015
- Fair RJ, Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspect Medicin Chem. 2014;28(6):25–64.
- Relman DA, Lipsitch M. Microbiome as a tool and a target in the effort to address antimicrobial resistance. Proc Natl Acad Sci U S A. 2018;115:12902–12910.
- McGuinness WA, Malachowa N. DeLeo FR vancomycin resistance in Staphylococcus aureus. Yale J Biol Med. 2017;23;90(2):269–281.
- Giersing BK, Dastgheyb SS, Modjarrad K, et al. Status of vaccine research and development of vaccines for Staphylococcus aureus. Vaccine. 2016;34(26):2962–2966.
- Redi D, Raffaelli CS, Rossetti B, et al. Staphylococcus aureus vaccine preclinical and clinical development: current state of the art. New Microbiol. 2018 Jul;41(3):208–213.
- Puertas-Prieto A, Lara-Oya A, Liébana Martos C, et al. Streptococcus agalactiae: prevention and vaccine development. Rev Esp Quimioter. 2017;30(5):312–318.
- Carig A, Gray RT, Edwards JL, et al. The potential impact of vaccination on the prevalence of gonorrhea. Vaccine. 2015;33:4520–4525.
- Andrews JR, Wamar FN, Charles RC, et al. Extensively drug-resistant typhoid – are conjugate vaccines arriving just in time? N Engl J Med. 2018 Oct 18;379(16):1493–1495.
- Andrews JR, Baker S, Marks F, et al. Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance. Lancet Infect Dis. 2019 Jan;19(1):e26–e30.
- Hegerle N, Choi M, Sinclair J, et al. Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomanas aeruginosa. PloS ONE. 2018;13(9):e0203143.
- Kwong JC, Maaten S, Upshur RE, et al. The effect of universal influenza immunization on antibiotic prescriptions: an ecological study. Clin Infect Dis. 2009;49:750–756.
- Neuzil KM, Mellen BG, Wright PF, et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342:225–231.
- Nichol KL, Mendelman PM, Mallon KP, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA. 1999;282(2):137–144.
- Monto AS, Webster A, Keene O. Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis. J Antimicrob Chemother. 1999;44(Suppl B):23–29.
- Kaiser L, Wat C, Mills T, et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med. 2003;163:1667–1672.
- Bloom DE, Black S, Salisbury D, et al. Antimicrobial resistance and the role of vaccines. Proc Natl Acad Sci U S A. 2018;18;115(51):12868–12871.